164 related articles for article (PubMed ID: 16971075)
21. Characterization of azacytidine/poly(L-lactic) acid particles prepared by supercritical antisolvent precipitation.
Argemí A; Vega A; Subra-Paternault P; Saurina J
J Pharm Biomed Anal; 2009 Dec; 50(5):847-52. PubMed ID: 19660889
[TBL] [Abstract][Full Text] [Related]
22. CO2 and fluorinated solvent-based technologies for protein microparticle precipitation from aqueous solutions.
Sarkari M; Darrat I; Knutson BL
Biotechnol Prog; 2003; 19(2):448-54. PubMed ID: 12675586
[TBL] [Abstract][Full Text] [Related]
23. Sub-micrometer-sized biodegradable particles of poly(L-lactic acid) via the gas antisolvent spray precipitation process.
Randolph TW; Randolph AD; Mebes M; Yeung S
Biotechnol Prog; 1993; 9(4):429-35. PubMed ID: 7763910
[TBL] [Abstract][Full Text] [Related]
24. Corticosteroid microparticles produced by supercritical-assisted atomization: process optimization, product characterization, and "in vitro" performance.
Della Porta G; Ercolino SF; Parente L; Reverchon E
J Pharm Sci; 2006 Sep; 95(9):2062-76. PubMed ID: 16850410
[TBL] [Abstract][Full Text] [Related]
25. Poly(hydroxybutyrate-hydroxyvalerate) microspheres containing progesterone: preparation, morphology and release properties.
Gangrade N; Price JC
J Microencapsul; 1991; 8(2):185-202. PubMed ID: 1765899
[TBL] [Abstract][Full Text] [Related]
26. Production of drug loaded microparticles by the use of supercritical gases with the aerosol solvent extraction system (ASES) process.
Bleich J; Müller BW
J Microencapsul; 1996; 13(2):131-9. PubMed ID: 8999119
[TBL] [Abstract][Full Text] [Related]
27. Supercritical antisolvent precipitation of nimesulide: preliminary experiments.
Moneghini M; Perissutti B; Vecchione F; Kikic I; Alessi P; Cortesi A; Princivalle F
Curr Drug Deliv; 2007 Jul; 4(3):241-8. PubMed ID: 17627498
[TBL] [Abstract][Full Text] [Related]
28. Micronization and microencapsulation of felodipine by supercritical carbon dioxide.
Chiou AH; Cheng HC; Wang DP
J Microencapsul; 2006 May; 23(3):265-76. PubMed ID: 16801239
[TBL] [Abstract][Full Text] [Related]
29. Effect of emulsification-diffusion parameters on the formation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) particles.
Göz E; Karakeçili A
Artif Cells Nanomed Biotechnol; 2016; 44(1):226-34. PubMed ID: 25058033
[TBL] [Abstract][Full Text] [Related]
30. Preparation of nanoparticles of Magnolia bark extract by rapid expansion from supercritical solution into aqueous solutions.
He S; Zhou B; Zhang S; Lei Z; Zhang Z
J Microencapsul; 2011; 28(3):183-9. PubMed ID: 21425944
[TBL] [Abstract][Full Text] [Related]
31. Microparticles of soy lecithin formed by supercritical processes.
Badens E; Magnan C; Charbit G
Biotechnol Bioeng; 2001 Jan; 72(2):194-204. PubMed ID: 11114657
[TBL] [Abstract][Full Text] [Related]
32. Development and evaluation of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and polycaprolactone microparticles of nimodipine.
Riekes MK; Junior LR; Pereira RN; Borba PA; Fernandes D; Stulzer HK
Curr Pharm Des; 2013; 19(41):7264-70. PubMed ID: 23489204
[TBL] [Abstract][Full Text] [Related]
33. Modified supercritical antisolvent method with enhanced mass transfer to fabricate drug nanoparticles.
Kakran M; Sahoo NG; Antipina MN; Li L
Mater Sci Eng C Mater Biol Appl; 2013 Jul; 33(5):2864-70. PubMed ID: 23623107
[TBL] [Abstract][Full Text] [Related]
34. Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release.
Thote AJ; Gupta RB
Nanomedicine; 2005 Mar; 1(1):85-90. PubMed ID: 17292062
[TBL] [Abstract][Full Text] [Related]
35. Production of griseofulvin nanoparticles using supercritical CO(2) antisolvent with enhanced mass transfer.
Chattopadhyay P; Gupta RB
Int J Pharm; 2001 Oct; 228(1-2):19-31. PubMed ID: 11576765
[TBL] [Abstract][Full Text] [Related]
36. Formulation of spray-dried phenytoin loaded poly(epsilon-caprolactone) microcarrier intended for brain delivery to treat epilepsy.
Li Z; Li Q; Simon S; Guven N; Borges K; Youan BB
J Pharm Sci; 2007 May; 96(5):1018-30. PubMed ID: 17455322
[TBL] [Abstract][Full Text] [Related]
37. Solubility and precipitation of nicotinic acid in supercritical carbon dioxide.
Rehman M; Shekunov BY; York P; Colthorpe P
J Pharm Sci; 2001 Oct; 90(10):1570-82. PubMed ID: 11745715
[TBL] [Abstract][Full Text] [Related]
38. Applications of supercritical fluids to enhance the dissolution behaviors of Furosemide by generation of microparticles and solid dispersions.
De Zordi N; Moneghini M; Kikic I; Grassi M; Del Rio Castillo AE; Solinas D; Bolger MB
Eur J Pharm Biopharm; 2012 May; 81(1):131-41. PubMed ID: 22266263
[TBL] [Abstract][Full Text] [Related]
39. Identification of physical-chemical variables affecting particle size following precipitation using a supercritical fluid.
Sacha GA; Schmitt WJ; Nail SL
Pharm Dev Technol; 2006; 11(2):195-205. PubMed ID: 16749530
[TBL] [Abstract][Full Text] [Related]
40. Environmentally benign formation of polymeric microspheres by rapid expansion of supercritical carbon dioxide solution with a nonsolvent.
Matsuyama K; Mishima K; Umemoto H; Yamaguchi S
Environ Sci Technol; 2001 Oct; 35(20):4149-55. PubMed ID: 11686380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
